Drug-based mobilisation of mesenchymal stem/stromal cells improves cardiac function post myocardial infarction

There is an unmet need for treatments that prevent the progressive cardiac dysfunction following myocardial infarction. Mesenchymal stem/stromal cells (MSCs) are under investigation for cardiac repair; however, culture expansion prior to transplantation is hindering their homing and reparative abili...

Descripción completa

Detalles Bibliográficos
Autores principales: Todorova, Veneta B., Baxan, Nicoleta, Delahaye, Matthew, Harding, Sian E., Rankin, Sara M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655717/
https://www.ncbi.nlm.nih.gov/pubmed/36263604
http://dx.doi.org/10.1242/dmm.049630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655717/
https://www.ncbi.nlm.nih.gov/pubmed/36263604
http://dx.doi.org/10.1242/dmm.049630

Ejemplares similares